Partner 3 Biscuspid Registry: A Prospective Randomized Controlled Mult-Center Study to Establish the safety and Effectiveness of Sapien 3 Transcatheter Heart Valve in low risk patients who have severe calcific aortic stenosis requiring aortic valve replacement

You may be eligible for this study if you meet the following criteria:

• Conditions:
  heart, cardiology,
• Age: - 99 Years
• Gender: All